scispace - formally typeset
Search or ask a question
Institution

German Red Cross

HealthcareBerlin, Germany
About: German Red Cross is a healthcare organization based out in Berlin, Germany. It is known for research contribution in the topics: Transplantation & Mesenchymal stem cell. The organization has 653 authors who have published 1146 publications receiving 40111 citations. The organization is also known as: Deutsches Rotes Kreuz & DRK.


Papers
More filters
Journal ArticleDOI
TL;DR: The HLA class II alleles differentiate between mono- and polyglandular autoimmunity in patients with autoimmune thyroid disease.
Abstract: The HLA class II genes are susceptibility genes for autoimmune endocrine diseases; however, scarce data are available pertaining to the determinants of genetic susceptibility to polyglandular autoimmunity (PGA). A total of 300 consecutive and unselected patients with either PGA or monoglandular autoimmune thyroid disease (AITD) and 100 healthy control subjects were genotyped for the HLA class II DRB1, -DQA1, and -DQB1 alleles. Compared to patients with AITD and controls, the HLA-DRB1*03 (pc =0.001), *04 (pc<0.001), -DQA1*03 (pc<0.001), and -DQB1*02 (pc =0.001) alleles were increased in patients with PGA. When dividing patients with Hashimoto's thyroiditis (HT) into those with PGA (PGA-HT) vs. those with HT as monoglandular disease, significant differences for the DRB1*03 (pc=0.001) and DQA1*03 (pc=0.001) alleles were observed. In contrast, the DQB1*02 allele was more prevalent in PGA patients with Graves' disease (PGA-GD) vs. those with monoglandular GD (pc=0.002). The HLA-DRB1*15 (pc =0.001), -DQA1*01 (pc =0.001), -DQB1*05 (pc =0.002) and -DQB1*06 (pc =0.002) alleles were significantly less present in PGA compared to monoglandular AITD and controls, thus indicating protective alleles. The HLA class II alleles differentiate between mono- and polyglandular autoimmunity in patients with autoimmune thyroid disease.

14 citations

Journal ArticleDOI
TL;DR: The use of genotyped reagent RBCs in antibody identification panels extends the range of detectable antibody specificities, accelerates the antibody identification, and improves the pre-transfusion diagnostics.
Abstract: Background The detection and identification of antibodies to red blood cell (RBC) antigens is one of the most important and challenging issues in transfusion medicine. Up to date there are 354 RBC antigens recognized by the International Society of Blood Transfusion (ISBT). The reagent RBCs used in commercial antibody screening and identification panels however are usually serologically typed for up to 40 clinically important antigens. Thus the identification of many antibody specificities remains impossible when using reagent RBCs with only limited information about their antigens. To improve the pre-transfusion diagnostics, we developed antibody identification panels with reagent RBCs serologically typed for 26 antigens and additionally genotyped for 30 blood group alleles. Methods The reagent RBCs in the panels were characterized serologically for the clinically most significant 'standard' antigens. The reagent RBC donors were additionally genotyped by using in-house PCR-SSP methods. The antibody identification was performed in the indirect antiglobulin test using untreated and papain-treated RBCs in the gel technique. Antibodies identified due to the genotype information were confirmed by serology using appropriate reference RBCs. Results Within a time period of 3 years and 8 months, 16,878 blood samples from 8,467 patients were tested in our reference laboratory. In total, 21 different antibodies from 10 different blood group systems could be identified in 126 patients (1.5%) due to the genotype information obtained for the reagent RBCs. Antibodies to antigens from the Knops system (53 patients; 42%, 8 patients with anti-Knb) and to Cartwright antigens (31 patients; 25%) were the most frequent. Conclusion The use of genotyped reagent RBCs in antibody identification panels extends the range of detectable antibody specificities, accelerates the antibody identification, and improves the pre-transfusion diagnostics.

14 citations

Journal ArticleDOI
TL;DR: Oral gene delivery of non‐viral vectors is an attractive strategy to achieve transgene expression and repeated vector administration is possible and may help to obtain durable transGene expression in a therapeutic range.

14 citations

Book ChapterDOI
01 Jan 2019
TL;DR: In this article, a case study of a pilot project in Peru that used sub-seasonal to seasonal (S2S) forecasts to prepare for extreme rainfall, in conjunction with seasonal and weather forecasts is presented.
Abstract: To take early action before a potential disaster, humanitarians continually request several weeks of preparation time. This is currently outside the realm of traditional weather forecasts, and sub-seasonal to seasonal (S2S) forecasts are poised to meet this demand. This chapter provides a case study of a pilot project in Peru that used S2S forecasts to prepare for extreme rainfall, in conjunction with seasonal and weather forecasts. The forecast triggered action in vain at that time, but it also provided a window into the planning and skill needs of the humanitarian sector. A key recommendation is to provide skill estimates for operational S2S forecasts so that disaster managers can evaluate the type of action that would be merited based on the forecast information.

14 citations

Journal ArticleDOI
TL;DR: It is found that both TLR7/8 agonists significantly improve the release of various proinflammatory cytokines by slanDCs and promote their tumor-directed cytotoxic activity.

14 citations


Authors

Showing all 658 results

NameH-indexPapersCitations
Johannes Oldenburg7258318790
Bodo Niggemann7127919475
Norbert Weissmann7138421187
Hubert Schrezenmeier6936016215
Triantafyllos Chavakis6524213247
Klaus Schwarz5820913407
Willy A. Flegel502336742
Rainer M. Bohle492356923
Torsten Tonn4815111328
Daniel Ricklin4614410713
Erhard Seifried442547967
Pamela S. Becker422576256
Karen Bieback4113510010
Halvard Bonig412164828
Julia Kzhyshkowska401265963
Network Information
Related Institutions (5)
Leiden University Medical Center
38K papers, 1.6M citations

83% related

Charité
64.5K papers, 2.4M citations

82% related

Karolinska University Hospital
33.5K papers, 1.2M citations

82% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

81% related

St. Jude Children's Research Hospital
19.2K papers, 1.2M citations

81% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20233
20227
202198
2020126
201995
201891